balsalazide has been researched along with Acute Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schroeder, KW | 1 |
| Cross, A; Doty, P; Hanson, J; Hardi, R; Johanson, J; Johnson, LK; Koval, G; Pruitt, R; Riff, D; Safdi, M; Winston, B; Wruble, L | 1 |
| Bettenhausen, D; Jahraus, CD; Malik, U; Sellitti, M; St Clair, WH | 1 |
| Aiello, F; Brandimarte, G; Elisei, W; Giorgetti, GM; Tursi, A | 1 |
| Gross, V | 1 |
| Hanauer, SB | 1 |
1 review(s) available for balsalazide and Acute Disease
| Article | Year |
|---|---|
Role of mesalazine in acute and long-term treatment of ulcerative colitis and its complications.
Topics: Acute Disease; Administration, Oral; Administration, Rectal; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Enema; Humans; Mesalamine; Phenylhydrazines; Prodrugs; Sulfasalazine; Time Factors | 2002 |
4 trial(s) available for balsalazide and Acute Disease
| Article | Year |
|---|---|
Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Child; Colitis, Ulcerative; Double-Blind Method; Humans; Mesalamine; Middle Aged; Phenylhydrazines; Safety; Treatment Outcome | 2002 |
Prevention of acute radiation-induced proctosigmoiditis by balsalazide: a randomized, double-blind, placebo controlled trial in prostate cancer patients.
Topics: Acute Disease; Aged; Aminosalicylic Acids; Anti-Ulcer Agents; Colon, Sigmoid; Double-Blind Method; Humans; Male; Mesalamine; Phenylhydrazines; Pilot Projects; Proctocolitis; Prostatic Neoplasms; Radiation Injuries; Rectum | 2005 |
Balsalazide and/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon.
Topics: Acute Disease; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Bifidobacterium; Diverticulitis, Colonic; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Agents; Humans; Lacticaseibacillus casei; Male; Mesalamine; Middle Aged; Phenylhydrazines; Pilot Projects; Probiotics; Recurrence; Treatment Outcome | 2007 |
Balsalazide led to greater remission rates and tolerance than mesalamine in acute ulcerative colitis.
Topics: Acute Disease; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Female; Humans; Male; Mesalamine; Phenylhydrazines; Randomized Controlled Trials as Topic | 1999 |
1 other study(ies) available for balsalazide and Acute Disease
| Article | Year |
|---|---|
Efficacy of different mesalamine-releasing drugs.
Topics: Acute Disease; Aminosalicylic Acids; Anti-Ulcer Agents; Clinical Trials as Topic; Colitis, Ulcerative; Humans; Mesalamine; Phenylhydrazines; Research Design | 1998 |